Teladoc Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-220.37	-13,659.53	-428.79	-485.14	-98.86	Upgrade
Depreciation & Amortization	351.32	270.64	219.62	78.09	44.95	Upgrade
Share-Based Compensation	201.55	217.85	302.59	475.53	66.7	Upgrade
Other Operating Activities	17.52	13,360	100.58	-121.99	17.08	Upgrade
Operating Cash Flow	350.02	189.29	193.99	-53.51	29.87	Upgrade
Operating Cash Flow Growth	84.91%	-2.42%	-	-	-	Upgrade
Capital Expenditures	-156.35	-172.76	-63.93	-26.04	-10.9	Upgrade
Acquisitions	0	0	-78.66	-567.43	-11.19	Upgrade
Change in Investments	0	2.51	60.9	2.5	47.1	Upgrade
Other Investing Activities	0	2.51	8.72	-	-	Upgrade
Investing Cash Flow	-156.35	-167.74	-72.98	-590.98	25.01	Upgrade
Share Issuance / Repurchase	11.13	12.39	42.59	59.04	36.66	Upgrade
Debt Issued / Paid	0	0	0	729.14	0	Upgrade
Other Financing Activities	-0.28	-5.89	-1.64	70.96	-1.57	Upgrade
Financing Cash Flow	10.85	6.5	40.95	859.14	35.09	Upgrade
Exchange Rate Effect	0.97	-3.34	-1.8	4.32	0.39	Upgrade
Net Cash Flow	204.53	28.05	161.96	214.65	89.98	Upgrade
Free Cash Flow	193.67	16.53	130.06	-79.55	18.97	Upgrade
Free Cash Flow Growth	1071.79%	-87.29%	-	-	-	Upgrade
Free Cash Flow Margin	7.44%	0.69%	6.40%	-7.27%	3.43%	Upgrade
Free Cash Flow Per Share	1.18	0.10	0.83	-0.88	0.26	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).